Droplet digital PCR (ddPCR) is a cutting-edge technique in genetic diagnostics, offering precise quantification of DNA and RNA. Renowned for its exceptional sensitivity and accuracy, ddPCR works by distributing DNA or RNA molecules into thousands of tiny reaction chambers before amplification, with the aim of obtaining only a single target molecule per reaction chamber. This is followed by an endpoint PCR process using fluorescent labeled probes. The resulting fluorescence signals allow for highly accurate quantification. The compartmentalization into numerous reaction chambers enables absolute quantification by measuring each reaction chamber independently and correlating the number of positive reactions directly with the initial quantity of target molecules in the sample.
ddPCR is invaluable in genetic diagnostics, as it detects genetic alterations at the molecular level. This capability is critical for identifying clinically relevant changes and supporting personalized medical treatments.
Applications of ddPCR:
●In cancer research, it enables the detection of rare variants, fusions and alterations in tumor tissues, which is crucial for early diagnosis and tailoring personalized therapy.
●In infectious diseases, it is used to quantitatively determine the viral load in the blood and to monitor the effectiveness of therapy.
●In genetics and heredity studies, it enables the detection and quantification of specific genetic variants in DNA samples, aiding in understanding inherited conditions.
ddPCR offers significant advantages, including accurate quantitative results, high sensitivity for the detection of rare genetic variants, and minimal interference from PCR inhibitors or background DNA. Potential challenges or limitations include cost, complexity, and throughput, as ddPCR can be more laborious than conventional PCR and requires specialized equipment and expertise. Nevertheless, the advantages of ddPCR and its potential for advancing genetic diagnostics and personalized medicine outweigh these challenges.
WAYS TO PARTNER WITH US
TarCET IVD Kits
CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form
Technology Transfer
Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing
Contact Us
Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.
BLOG ARTICLES
February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…
Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…
Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…
Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact …
A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc…
Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of …
It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access…
Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is…
A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti…
Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati…
